AstraZeneca shares decline 7.5% despite solid results, rosy outlook

Article Abstract:

AstraZeneca PLC saw its share value decline by 7.5% in spite of a strong performance in 1999 by the firm's pharmaceutical division. The company also provided a positive profit and sales forecast for the 2000 year.

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code:

AstraZeneca shares fall 2.5% after cutting sales outlook

Article Abstract:

AstraZeneca PLC saw its share value decline by 2.5% after the company lowered its sales forecasts by the 2000 year. The company has experienced a slow 2000 third-quarter.

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code:

AstraZeneca may remain volatile stock

Article Abstract:

AstraZeneca, an Anglo-Swedish drugmaker, saw its stocks dive 10% over the last 10 days, in spite of announcements of reserch on some very promising medicines. The decline is triggered by AstraZeneca's decision to repurchase one million of its own shares, and stocks are expected to remain volatile for a while.

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code: